Literature DB >> 9655846

Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study.

S M Rawls1, J F Mcginty.   

Abstract

Regulation of extracellular glutamate levels by muscarinic receptors in the striatum of unanesthetized rats was investigated by microdialysis. Extracellular glutamate levels were elevated by intrastriatal perfusion of L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC), a competitive substrate of plasma membrane excitatory amino acid transporters. The nonselective muscarinic agonist, oxotremorine (0.5-54 microM) significantly decreased L-trans-PDC-evoked glutamate levels in a concentration-dependent manner. Scopolamine (0.1-10 microM), a nonselective muscarinic receptor antagonist, reversed the effect of oxotremorine, which confirms that muscarinic receptor activation mediated the reduction of L-trans-PDC-evoked glutamate levels. In addition, scopolamine (10 microM) significantly elevated basal extracellular glutamate levels, an effect prevented by oxotremorine, which suggests that acetylcholine tonically regulates glutamatergic transmission in the striatum. Previous data from this laboratory have shown that L-trans-PDC-evoked glutamate levels are partially calcium-dependent. The present study demonstrated that attenuation of L-trans-PDC-evoked glutamate levels by reduced calcium was not altered by oxotremorine. Therefore, it is likely that muscarinic receptors regulate calcium-dependent glutamate release evoked by L-trans-PDC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655846

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 2.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

3.  Antagonism of Muscarinic Acetylcholine Receptors Alters Synaptic ERK Phosphorylation in the Rat Forebrain.

Authors:  Li-Min Mao; Henry H Wang; John Q Wang
Journal:  Neurochem Res       Date:  2016-12-28       Impact factor: 3.996

Review 4.  Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.

Authors:  Wayne C Drevets; Carlos A Zarate; Maura L Furey
Journal:  Biol Psychiatry       Date:  2012-11-28       Impact factor: 13.382

5.  Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice.

Authors:  A J Saylor; J F McGinty
Journal:  Genes Brain Behav       Date:  2008-08-04       Impact factor: 3.449

6.  Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.

Authors:  Bhavya Voleti; Andrea Navarria; Rong-Jian Liu; Mounira Banasr; Nanxin Li; Rose Terwilliger; Gerard Sanacora; Tore Eid; George Aghajanian; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-14       Impact factor: 13.382

7.  Control of striatal signaling by g protein regulators.

Authors:  Keqiang Xie; Kirill A Martemyanov
Journal:  Front Neuroanat       Date:  2011-08-08       Impact factor: 3.856

8.  The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.

Authors:  Hanjie Yu; Mengmeng Li; Xinbei Shen; Dan Lv; Xin Sun; Jinting Wang; Xinmei Gu; Jingning Hu; Chuang Wang
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

Review 9.  Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.

Authors:  Eric S Wohleb; Danielle Gerhard; Alex Thomas; Ronald S Duman
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.